The landscape of Cannabis business in Germany is changing rapidly. The new legislation put in motion by the German government this January will make medical marijuana treatment accessible to a wider group of patients. However, the specifics of the treatments, the import, grow and production are still to be determined by a federal cannabis agency, run by the Federal Institute for drugs and medical devices.
How will the business around medical marijuana develop and what are the lessons we can learn from the United States and Canada? We will discuss the future of the “Cannabusiness” with two thought leaders of the emerging industry: CEO of MedCann, Dr. Pierre Debs,
We will discuss the future of the “Cannabusiness” with two thought leaders of the emerging industry:
Dr. Pierre Debs, CEO of MedCann, licensed distributor of Canopy Growth products in Europe
Michael Knodt, veteran activist and journalist focusing on cannabis legalization for the past 20 years
The talk is being hosted by the CannaBusinessClub Berlin and Weedmaps.